Chargement en cours...
Target/therapies for chronic recurrent erythema nodosum leprosum
A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and...
Enregistré dans:
| Publié dans: | Indian J Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer - Medknow
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7446680/ https://ncbi.nlm.nih.gov/pubmed/32874007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijp.IJP_788_19 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|